Related Experiment Video
Updated: Jun 9, 2026
11:13
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 15, 2013
Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An
Alexandra Linn1,2, Noah Boton3, Susan E Beekmann4
1Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Journal of the Pediatric Infectious Diseases Society
|January 19, 2026
Summary
Pediatric infectious diseases physicians are increasingly using newer treatments like vancomycin, fidaxomicin, bezlotoxumab, and fecal microbiota transplantation for Clostridioides difficile infection (CDI). This trend indicates a need for updated clinical guidelines for pediatric CDI management.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Therapeutics
Background:
- Clostridioides difficile infection (CDI) poses a significant challenge in pediatric healthcare settings.
- Current management strategies for pediatric CDI are evolving.
- Physician preferences and adoption of novel therapies are crucial for effective treatment.
Purpose of the Study:
- To investigate the current management preferences of pediatric infectious diseases physicians for Clostridioides difficile infection (CDI).
- To explore the utilization of established and emerging therapies, including vancomycin, fidaxomicin, bezlotoxumab, and fecal microbiota transplantation (FMT).
- To identify trends in therapeutic choices and the need for updated clinical guidelines.
Main Methods:
- A survey was distributed to pediatric infectious diseases physicians.
- The survey was conducted through the Emerging Infections Network.
- Physician preferences for CDI management options were queried.
Main Results:
- Physicians are increasingly considering newer therapeutic options for pediatric CDI.
- Adjunctive therapies are being more frequently incorporated into treatment plans.
- A notable shift towards exploring advanced treatment modalities was observed.
Conclusions:
- Pediatric infectious diseases physicians are adopting a broader range of treatments for CDI.
- The evolving treatment landscape necessitates the development of updated pediatric CDI guidelines.
- Further research and guideline refinement are essential to optimize patient outcomes.
Related Concept Videos
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...